Human metapneumovirus (hMPV) cases continue to be documented in various states throughout India, although there is a noted decline in the number of reported cases. Currently, there is no vaccine available to prevent or treat this infection; however, its relatively mild symptoms enable healthcare professionals to manage and control the condition effectively. It is important to note that hMPV presents symptoms similar to those of other respiratory viruses, including COVID-19, influenza, and respiratory syncytial virus (RSV), which can lead to confusion. While all these viruses impact the respiratory system, they exhibit differences in symptoms, causes, treatment approaches, diagnostic methods, and severity. Continue reading to understand how hMPV distinguishes itself from these other viral infections.

What is hMPV?

Human metapneumovirus is a respiratory pathogen that produces symptoms akin to those of the common cold, such as sneezing, coughing, mild fever, nasal congestion, and throat discomfort. These symptoms generally resolve spontaneously within a period of 2 to 5 days, with the majority of individuals recovering without the need for medical intervention. Nevertheless, in uncommon instances, the virus may result in more serious manifestations, including difficulty breathing, exacerbations of asthma, or illnesses such as bronchiolitis, bronchitis, and pneumonia, which could necessitate medical care.

Initially identified in 2001, this virus is classified within the Pneumoviridae family, which also encompasses respiratory syncytial virus (RSV), as reported by the Centers for Disease Control and Prevention (CDC). It is prevalent globally and is transmitted through close interactions with infected persons or via contaminated surfaces. While it can impact individuals across all age groups, it is especially prevalent among at-risk populations, including young children, the elderly, and individuals with compromised immune systems.

HMPV vs Covid-19

Human metapneumovirus and COVID-19 are both classified as respiratory viruses; however, they originate from distinct pathogens and can manifest with varying symptoms. Covid-19, which is caused by the SARS-CoV-2 virus, emerged as a novel and highly transmissible virus that predominantly impacts the respiratory system. Although the symptoms of COVID-19 frequently overlap with those of hMPV—such as fever, cough, and shortness of breath—COVID-19 is associated with a higher likelihood of severe complications, including pneumonia, acute respiratory distress syndrome (ARDS), multi-organ failure, and even mortality, particularly among older adults and individuals with pre-existing health conditions, according to the Mayo Clinic.

The primary differences between these two viruses are evident in their modes of transmission and severity. COVID-19 is more easily transmitted than hMPV and has previously led to a global pandemic. Furthermore, Covid-19 can result in prolonged symptoms, commonly referred to as "long Covid," a phenomenon not typically associated with human metapneumovirus. Another significant distinction is that COVID-19 has demonstrated the capacity for year-round transmission, with peaks occurring in specific seasons, such as winter, when respiratory infections are prevalent. In contrast, hMPV primarily circulates during the colder months, indicating its seasonal nature.

HMPV vs respiratory syncytial virus (RSV)

Both human metapneumovirus and respiratory syncytial virus (RSV) are respiratory infections that predominantly impact children, although they can also lead to significant health issues in older adults. While these viruses are closely related, they are distinct entities. They are classified within the Paramyxoviridae family and exhibit overlapping symptoms, such as cough, fever, and breathing difficulties, yet they vary in terms of severity and overall impact.

RSV is recognized as a primary cause of respiratory illness in infants and young children, frequently resulting in conditions such as bronchiolitis and pneumonia. It is particularly associated with severe lower respiratory infections, especially during the winter season, according to the American Lung Association. In contrast, human metapneumovirus generally produces milder symptoms akin to those of the common cold, although it can still lead to serious illness in at-risk groups, including children, the elderly, and individuals with compromised immune systems.

Furthermore, RSV is more thoroughly researched, with available vaccines and treatment options to address severe cases, while human metapneumovirus remains less understood, resulting in fewer treatment alternatives.

HMPV vs influenza

HMPV and influenza are both viral infections that exhibit similar symptoms, including fever, body aches, cough, and sore throat. Nevertheless, they are caused by distinct viruses and exhibit different behaviours within the human body. Influenza, which is caused by the influenza virus, is a highly contagious respiratory illness that can result in serious health issues and potentially life-threatening complications, such as pneumonia, as noted by the World Health Organization. This infection can impact individuals of all ages and is primarily transmitted through respiratory droplets produced by coughing and sneezing. In certain instances, influenza may lead to hospitalization or even fatalities.

Human metapneumovirus, in contrast, is less prevalent and generally results in milder illnesses compared to influenza; however, it can still cause significant respiratory issues in at-risk groups. Both influenza and human metapneumovirus can manifest symptoms such as cough, fever, and sore throat, yet influenza typically presents more abruptly and with greater severity. In comparison, the symptoms associated with human metapneumovirus tend to emerge more gradually and are less frequently associated with severe complications, unlike those observed with influenza.

Furthermore, while both influenza and human metapneumovirus are transmitted through respiratory droplets, influenza exhibits a higher mutation rate and transmission efficiency, which contributes to its propensity for causing seasonal outbreaks.

Read Also: Hair Care on a Budget: 6 Economical Alternatives to Kerastase's Anti-Hair Fall Serum

Get the latest Bollywood entertainment news, trending celebrity news, latest celebrity news, new movie reviews, latest entertainment news, latest Bollywood news, and Bollywood celebrity fashion & style updates!

HOW DID YOU LIKE THIS ARTICLE? CHOOSE YOUR EMOTICON!